Literature DB >> 18463928

The effect of perineural invasion on overall survival in patients with gastric carcinoma.

Luo Tianhang1, Fang Guoen, Bi Jianwei, Ma Liye.   

Abstract

AIMS: The availability of different treatment options for gastric carcinoma has reopened the question of correct definition of high-risk categories, which may help in identifying patients with high risk for poor prognosis who would benefit more from adjuvant therapy after operation. Perineural invasion (PNI) seems to provide useful information for management. Therefore, we examined the effect of PNI on overall survival (OS) in patients with gastric carcinoma and the association between PNI and other clinical and pathological factors. PATIENTS AND METHODS: A total of 1,632 patients with gastric carcinoma from 2000 to 2005 were analyzed retrospectively. Paraffin sections of surgical specimens from all patients who underwent gastric resection were stained with laminin. If carcinoma cells infiltrated into the perineurium or neural fascicles, PNI was assessed as positive. Survival analysis was done in 1,372 patients with T1-T4 tumors who underwent curative resection. RESULT: PNI was positive in 518 of the 1,632 patients (31.7%). The size of tumors, T stage, differentiation of tumor, and clinical stage were significantly related to PNI positivity. The proportion of large tumors was significantly higher in PNI-positive patients than in PNI-negative patients (P < 0.01). As the depth of gastric mural invasion or clinical stage increased, the positive rate of PNI also increased. The OS of the PNI-positive patients was significantly shorter than that of the PNI-negative patients in the univariate analysis (P < 0.01). At multivariate Cox proportional hazards model of OS analysis, the positivity of PNI appeared to be an independent prognostic factor for OS (hazards ratio [HR] = 3.23, 95%CI = 2.6-8.11, P < 0.01), which was also influenced by tumor differentiation, T stage, and clinical stage (P < 0.01).
CONCLUSION: Our results suggested that the incidence of PNI was high in gastric carcinoma and that it corresponded to the progression of disease. It could provide additional information for identifying patients who are at high risk for poor prognosis. PNI can be a candidate for a new kind of prognostic parameters.

Entities:  

Mesh:

Year:  2008        PMID: 18463928     DOI: 10.1007/s11605-008-0529-4

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  15 in total

1.  Criteria for extramural perineural invasion as a prognostic factor in rectal cancer.

Authors:  H Ueno; K Hase; H Mochizuki
Journal:  Br J Surg       Date:  2001-07       Impact factor: 6.939

2.  Molecular epidemiology of gastric cancer.

Authors:  Teresa Starzyńska
Journal:  Dig Dis       Date:  2007       Impact factor: 2.404

3.  Prognostic significance of metastatic lymph node ratio in T3 gastric cancer.

Authors:  Woo Jin Hyung; Sung Hoon Noh; Chang Hak Yoo; Ji Hun Huh; Dong Woo Shin; Ki Hyeok Lah; Jun Ho Lee; Seung Ho Choi; Jin Sik Min
Journal:  World J Surg       Date:  2001-12-21       Impact factor: 3.352

4.  Expression of highly polysialylated neural cell adhesion molecule in pancreatic cancer neural invasive lesion.

Authors:  K Kameda; H Shimada; T Ishikawa; A Takimoto; N Momiyama; S Hasegawa; K Misuta; A Nakano; Y Nagashima; Y Ichikawa
Journal:  Cancer Lett       Date:  1999-04-01       Impact factor: 8.679

5.  Prediction of lymph node metastasis and perineural invasion of biliary tract cancer by selected features from cDNA array data.

Authors:  Katsuhiko Murakawa; Mitsuhiro Tada; Minoru Takada; Eiji Tamoto; Gaku Shindoh; Ken-ichi Teramoto; Akihiro Matsunaga; Kazuteru Komuro; Motoshi Kanai; Akiko Kawakami; Yoshie Fujiwara; Nozomi Kobayashi; Katsutoshi Shirata; Norihiro Nishimura; Shun-ichi Okushiba; Satoshi Kondo; Jun-ichi Hamada; Hiroyuki Katoh; Takashi Yoshiki; Tetsuya Moriuchi
Journal:  J Surg Res       Date:  2004-12       Impact factor: 2.192

6.  The significance of perineural invasion as a prognostic factor in patients with gastric carcinoma.

Authors:  Nüvit Duraker; Servet Sişman; Günay Can
Journal:  Surg Today       Date:  2003       Impact factor: 2.549

Review 7.  Carcinomatosis from gastrointestinal cancer.

Authors:  Paul H Sugarbaker
Journal:  Ann Med       Date:  2004       Impact factor: 4.709

8.  [TNM classification: cancer of the stomach].

Authors:  K Maruyama; M Sasako; T Sano; H Katai; T Kinoshita; T Fukagawa
Journal:  Gan To Kagaku Ryoho       Date:  1998-09

9.  Perineural invasion of carcinoma of the pancreas and biliary tract.

Authors:  T Nagakawa; K Mori; T Nakano; M Kadoya; H Kobayashi; T Akiyama; M Kayahara; T Ohta; K Ueno; Y Higashino
Journal:  Br J Surg       Date:  1993-05       Impact factor: 6.939

10.  Survivin expression and its clinical significance in pancreatic cancer.

Authors:  Myung Ah Lee; Gyeong-sin Park; Hee-Jung Lee; Ji-Han Jung; Jin-Hyoung Kang; Young Seon Hong; Kyung Shik Lee; Dong-gu Kim; Seung-Nam Kim
Journal:  BMC Cancer       Date:  2005-10-04       Impact factor: 4.430

View more
  14 in total

1.  Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer.

Authors:  Ahmet Bilici; Mesut Seker; Bala Basak Oven Ustaalioglu; Burcak Yilmaz; Alper Doventas; Taflan Salepci; Mahmut Gumus
Journal:  Med Oncol       Date:  2009-11-03       Impact factor: 3.064

2.  Preliminary study correlating CX3CL1/CX3CR1 expression with gastric carcinoma and gastric carcinoma perineural invasion.

Authors:  Cheng-Yu Lv; Tao Zhou; Wei Chen; Xin-Dao Yin; Jian-Hong Yao; Yi-Fan Zhang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

3.  Prognostic Value of Perineural Invasion in Resected Gastric Cancer Patients According to Lauren Histotype.

Authors:  Lorenzo De Franco; Daniele Marrelli; Costantino Voglino; Carla Vindigni; Francesco Ferrara; Giulio Di Mare; Livio Iudici; Mario Marini; Franco Roviello
Journal:  Pathol Oncol Res       Date:  2017-05-30       Impact factor: 3.201

4.  Inclusion of Perineural Invasion with AJCC-TNM Staging: Outcomes from a South Asian Cohort of Curatively Treated Gastric Cancer Patients.

Authors:  Dillip Kumar Muduly; Madhabananda Kar; Mahesh Sultania; Mohammed Shahin; Susama Patra; Vishwajeet Singh; Mohammed Imaduddin; Sudipta Mohakud; Hemant Kumar Nayak; Manas Kumar Panigraphi; Saroj Kumar Das Majumdar; Dilip Kumar Parida
Journal:  J Gastrointest Cancer       Date:  2022-06-24

Review 5.  Nerves in gastrointestinal cancer: from mechanism to modulations.

Authors:  Nathalie Vaes; Musa Idris; Werend Boesmans; Maria M Alves; Veerle Melotte
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-09-02       Impact factor: 73.082

Review 6.  Tumour invasion and dissemination.

Authors:  Ryan Lusby; Philip Dunne; Vijay K Tiwari
Journal:  Biochem Soc Trans       Date:  2022-06-30       Impact factor: 4.919

7.  Predictive factors for recurrence in T2N0 and T3N0 gastric cancer patients.

Authors:  Hiroaki Saito; Yuki Murakami; Kozo Miyatani; Hirohiko Kuroda; Tomoyuki Matsunaga; Yoji Fukumoto; Tomohiro Osaki; Masahide Ikeguchi
Journal:  Langenbecks Arch Surg       Date:  2016-07-27       Impact factor: 3.445

8.  Incorporation of perineural invasion of gastric carcinoma into the 7th edition tumor-node-metastasis staging system.

Authors:  Nan Jiang; Jing-Yu Deng; Yong Liu; Bin Ke; Hong-Gen Liu; Han Liang
Journal:  Tumour Biol       Date:  2014-06-28

9.  Clinical significance of perineural invasion diagnosed by immunohistochemistry with anti-S100 antibody in Stage I-III colorectal cancer.

Authors:  Yoshifumi Shimada; Tomoki Kido; Hitoshi Kameyama; Mae Nakano; Ryoma Yagi; Yosuke Tajima; Takuma Okamura; Masato Nakano; Masayuki Nagahashi; Takashi Kobayashi; Masahiro Minagawa; Shin-Ichi Kosugi; Toshifumi Wakai; Yoichi Ajioka
Journal:  Surg Today       Date:  2014-12-13       Impact factor: 2.549

Review 10.  Prognostic value of perineural invasion in gastric cancer: a systematic review and meta-analysis.

Authors:  Jing Deng; Qihan You; Yang Gao; Qing Yu; Peng Zhao; Yulong Zheng; Weijia Fang; Nong Xu; Lisong Teng
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.